UCLA researchers at the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research and the Jonsson Comprehensive Cancer Center have discovered a new agent that may be useful in strategies to remove pluripotent stem cells that fail to differentiate from their progeny, tissue-specific cells, potentially resulting in safer therapies for patients.
Fuente : http://www.eurekalert.org/pub_releases/2013-04/uoc…
Hacer un comentario